STEINMAN LAWRENCE - Insider Non-Derivative Transactions at Pasithea Therapeutics Corp. (KTTA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 28, 2025, STEINMAN LAWRENCE's relationship to Pasithea Therapeutics Corp. (KTTA) is Director, and currently has 199,691 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KTTA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

STEINMAN LAWRENCE - Insider Non-Derivative Transactions of KTTA Common Stock

STEINMAN LAWRENCE - Insider Non-Derivative Transactions at KTTA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 29, 2025	P -- (Common Stock)	133333	0.75	199691
Jun 3, 2023	P -- (Common Stock)	30000	0.43	1327174